Soleno Therapeutics Inc
SLNOCIK 0001484565 · Every Form 4 filed by insiders at this issuer. See financials →
Annual report (10-K)
Latest 10-K/A filed Apr 30, 2026. Sentiment + YoY language diff vs prior year. Read sections →
Signal:NeutralFull-doc fallback
Full filing:tone 0.0025
Sentiment via Loughran-McDonald lexicon · YoY diff via Jaccard similarity + paragraph set difference.
Recent 8-K announcements
Per-item disclosure feed. Item 2.02 is the earnings release.
Top insiders
Most active reporters at Soleno Therapeutics Inc
| Name | Roles | Filings |
|---|---|---|
| Pauls Matthew | Director | 5 |
| Sinclair Andrew | Director | 5 |
| Vivo Opportunity Fund Holdings, L.P. | 10% Owner | 5 |
| Vivo Opportunity, LLC | 10% Owner | 5 |
| Volck Birgitte | Director | 5 |
Top performers
Insiders ranked by realized 90-day signed return on their open-market trades at Soleno Therapeutics Inc. Minimum 3 scored trades. Returns are signed - a sale followed by a rally counts against the insider.
| # | Insider | Trades | Win rate | Avg | Median | Best | Worst |
|---|---|---|---|---|---|---|---|
| 1 | Edelman Joseph | 27 | 59% | +21.6% | +49.5% | +49.5% | -29.5% |
| 2 | Perceptive Advisors LLC | 27 | 59% | +21.6% | +49.5% | +49.5% | -29.5% |
| 3 | Perceptive Life Sciences Master Fund Ltd | 27 | 59% | +21.6% | +49.5% | +49.5% | -29.5% |
| 4 | Schuler Jack W | 37 | 14% | -95.2% | -99.1% | +62.5% | -194.5% |
| 5 | MacKaness James H | 38 | 5% | -31.5% | -25.8% | +8.7% | -87.5% |
| 6 | Yen Kristen | 37 | 8% | -30.3% | -24.1% | +16.0% | -87.5% |
| 7 | Anish Bhatnagar | 41 | 10% | -28.4% | -24.3% | +45.1% | -87.5% |
| 8 | Huang Michael F. | 9 | 0% | -27.3% | -27.3% | -27.3% | -27.3% |
| 9 | Manning Meredith | 9 | 0% | -27.3% | -27.3% | -27.3% | -27.3% |
| 10 | Hirano Patricia C | 46 | 11% | -26.2% | -24.0% | +32.8% | -87.5% |
All filings
160 Form 4 / 4-A filings, newest first
| Filed | Top transaction | Shares | Price | Value | ||
|---|---|---|---|---|---|---|